Piper Sandler Maintains Overweight on CVRx, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Matt O'Brien maintains an Overweight rating on CVRx but lowers the price target from $33 to $15.
May 01, 2024 | 1:54 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler maintains an Overweight rating on CVRx but reduces the price target from $33 to $15.
The reduction in price target by Piper Sandler from $33 to $15, while maintaining an Overweight rating, suggests a reassessment of CVRx's valuation or growth prospects. This significant decrease in price target could lead to short-term negative sentiment among investors, potentially impacting the stock's price negatively.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100